Want to join the conversation?
$PAHC expects net sales of $750-770MM for FY17, up to 2% growth over 2016. Animal Health sales are expected to be $495-510MM, an increase of 2-5%. Mineral Nutrition revenue is to decline slightly, with volume growth offset by reduced pricing related to commodity prices. Performance Products revenue is expected to be stable or decline slightly.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?